📰 Registration Statement News
Page 38 - Registration Statement News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Registration Statement. Real-time updates on events, politics, business and more.
February 27, 2024
63 MW site, planned to be energized in Q2, will be Hut 8’s newest North American mining operation Site expected to have up to approximately 3.6 EH/s of...
February 27, 2024
63 MW site, planned to be energized in Q2, will be Hut 8’s newest North American mining operation Site expected to have up to approximately 3.6 EH/s of self-mining capacity Hut 8 to utilize its...
February 27, 2024
Nocturne Acquisition Corporation Announces Postponement of Extraordinary ...
February 27, 2024
IMMINENT MSS DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Maison ...
February 27, 2024
BROOMFIELD, CO, Feb. 27, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire - Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare...
February 27, 2024
Janux Therapeutics, Inc. (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technology to its Tumor Activated T Cell Engager (TRACTr) and Tumor Activated...
February 27, 2024
Victor, NY, Feb. 27, 2024 (GLOBE NEWSWIRE) -- EDOC Acquisition Corp. (Nasdaq: ADOC) (“EDOC”) announced today that it has postponed its extraordinary general meeting of its shareholders (the “Meeting”) to approve its proposed initial business combination, which was re-scheduled from February 26, 2024 to February 28, 2024, has been further postponed to 4:30p.m. Eastern Time, on Tuesday, March 5, 2024. At the Meeting, shareholders of EDOC will be asked to vote on proposa...
February 27, 2024
Janux Therapeutics, Inc. , a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technology to its Tumor Activated T Cell...
February 25, 2024
IMMINENT MSS DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Maison ...